| Robert J Willer Jr, DO | |
|
2000 S 900 E, Salt Lake City, UT 84105-3208 | |
| (801) 464-7788 | |
| (801) 464-7787 |
| Full Name | Robert J Willer Jr |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 2000 S 900 E, Salt Lake City, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417374323 | NPI | - | NPPES |
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets, 25 mg, 50 mg, 100 mg and 200 mg, a generic equivalent to GlaxoSmithKline's Lamictal® ODT.
CPEX Pharmaceuticals Inc. today announced that its partner, Serenity Pharmaceuticals, has entered into a global agreement with Allergan, Inc. for the development and commercialization of Ser-120, a product candidate currently in Phase III clinical trials for the treatment of nocturia that utilizes CPEX's patented intranasal drug delivery technology.
The Royal College of Nursing has also warned that hospital wards are becoming unsafe as there are just not enough frontline workers to look after patients or prevent the spread of infection. There are also fears that nurses are so overworked they are unable to carry out their most basic duties of care such attending to the needs of the vulnerable elderly.
› Verified 4 days ago
| Entity Name | University Of Utah Pediatric Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487018974 PECOS PAC ID: 0547552473 Enrollment ID: O20160713000371 |
News Archive
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets, 25 mg, 50 mg, 100 mg and 200 mg, a generic equivalent to GlaxoSmithKline's Lamictal® ODT.
CPEX Pharmaceuticals Inc. today announced that its partner, Serenity Pharmaceuticals, has entered into a global agreement with Allergan, Inc. for the development and commercialization of Ser-120, a product candidate currently in Phase III clinical trials for the treatment of nocturia that utilizes CPEX's patented intranasal drug delivery technology.
The Royal College of Nursing has also warned that hospital wards are becoming unsafe as there are just not enough frontline workers to look after patients or prevent the spread of infection. There are also fears that nurses are so overworked they are unable to carry out their most basic duties of care such attending to the needs of the vulnerable elderly.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert J Willer Jr, DO Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 464-7788 | Robert J Willer Jr, DO 2000 S 900 E, Salt Lake City, UT 84105-3208 Ph: (801) 464-7788 |
News Archive
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets, 25 mg, 50 mg, 100 mg and 200 mg, a generic equivalent to GlaxoSmithKline's Lamictal® ODT.
CPEX Pharmaceuticals Inc. today announced that its partner, Serenity Pharmaceuticals, has entered into a global agreement with Allergan, Inc. for the development and commercialization of Ser-120, a product candidate currently in Phase III clinical trials for the treatment of nocturia that utilizes CPEX's patented intranasal drug delivery technology.
The Royal College of Nursing has also warned that hospital wards are becoming unsafe as there are just not enough frontline workers to look after patients or prevent the spread of infection. There are also fears that nurses are so overworked they are unable to carry out their most basic duties of care such attending to the needs of the vulnerable elderly.
› Verified 4 days ago
Kristina Mckinley, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: University Of Utah Hospital, 30 North 1900 East, Rm 1c412, Salt Lake City, UT 84132 Phone: 801-581-2401 | |
Kaitlin Carpenter, Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Mario Capecchi Dr, Salt Lake City, UT 84113 Phone: 801-662-1000 | |
Dr. Thomas Patrick Curtin, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 81 N Mario Capecchi Dr, Salt Lake City, UT 84113 Phone: 801-662-5700 | |
Anastasiya Mankouski, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5121 S Cottonwood St, Salt Lake City, UT 84107 Phone: 801-507-7000 | |
Joslynn Marie Hoburg, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 295 S Chipeta Way Rm 2s010, Salt Lake City, UT 84108 Phone: 801-581-2121 | |
George W Delavan, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 44 N Mario Capecchi Dr, Salt Lake City, UT 84132 Phone: 801-584-8239 Fax: 801-584-8588 | |
Michelle Ploutz, Pediatrics Medicare: Medicare Enrolled Practice Location: 100 N Mario Capecchi Dr, Salt Lake City, UT 84113 Phone: 801-662-1000 Fax: 018-213-7778 |